Abu Dhabi, UAE- May, 2024- Burjeel Holdings is set to feature its innovative solutions and complex care capabilities at the upcoming Abu Dhabi Global Healthcare Week (ADGHW). At the event, the Group will highlight its advanced offerings and patient-centered care through its flagship facility, Burjeel Medical City (“BMC”). This showcase, in line with the theme ‘Safeguarding Your Health at the World’s Safest City’, highlights the Group’s commitment to reinforcing Abu Dhabi’s reputation as a prime destination for medical tourism. The event is scheduled to take place from May 13-15 at the Abu Dhabi National Exhibition Centre (ADNEC).

Key Specialties in Focus

The BMC pavilion, at booth number B030, will spotlight significant advancements from its oncology department, underscoring its integrated approach to cancer care, which includes the latest in precision medicine and targeted therapies and ensuring comprehensive treatment plans tailored to individual patient needs. Key complex care specialties including Bone Marrow Transplantation, Hematology, Advanced Orthopedics, Fetal Medicine and Pediatric subspecialties will also be featured.

Also read: Burjeel Holdings Announces Launch of Specialized Day Surgery Centers in KSA

Moreover, The exhibition comes on the heels of groundbreaking strides in the Group’s multi-organ transplant program. Recently, Dr. Rehan Saif, Director of the Burjeel Abdominal Multi-Organ Transplant Program, and his team successfully completed BMC’s first liver transplant. This achievement, along with the center’s established kidney transplant capabilities, demonstrates a major leap forward in the Group’s medical expertise and underscores its commitment to pioneering cutting-edge treatments. The pavilion will also highlight BMC’s soon-to-be-launched Advanced Neuroscience Institute that will specialize in cutting-edge treatments for neurological disorders and will be led by the renowned Dr. Souhel Najjar.

Click here to join our WhatsApp channel

“We are pleased to be part of this significant event and look forward to contributing to and learning from the global dialogue on healthcare advancement. Our participation is a demonstration of our dedication to elevating healthcare standards regionally and globally, driving forward the vision of making Abu Dhabi a hub for medical excellence and innovation,” said Mr. John Sunil, CEO of Burjeel Holdings.

ADGHW will also serve as a platform to engage with Burjeel Holdings’ leading medical experts and participate in discussions that span a broad array of topics, from industry advancements to cutting-edge research and treatment strategies. Also, Throughout the event the Group is expected to enter into collaborations with key partners to enhance patient experiences and push the boundaries of technological advancements, research, and innovation.